ストックスクリーナーアプリを入手
114.64
0.61%
0.695
Ligand Pharmaceuticals Inc (LGND) 最新ニュース
Wellington Management Group LLP Trims Stock Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
What is Zacks Small Cap's Forecast for LGND FY2025 Earnings? - MarketBeat
Zacks Small Cap Has Strong Estimate for LGND FY2026 Earnings - MarketBeat
Fmr LLC Raises Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Ligand Pharmaceuticals: A Strong Growth Trajectory with Impressive Returns and Strategic Advancements - mediahousepress
LGND: 2025 View Calls for 17% Topline Growth - Zacks Small Cap Research
Ligand Pharmaceuticals' SWOT analysis: diversified royalty model drives stock growth - Investing.com Australia
Barclays Boosts Ligand Pharmaceuticals (NASDAQ:LGND) Price Target to $160.00 - MarketBeat
Ligand Pharmaceuticals' SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa
Ligand Pharmaceuticals' SWOT analysis: stock poised for growth amid challenges - Investing.com India
Ligand Pharmaceuticals' SWOT analysis: royalty aggregator stock poised for growth - Investing.com
What is HC Wainwright's Estimate for LGND FY2025 Earnings? - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 6,031 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Ligand price target raised to $151 from $135 at Oppenheimer - Yahoo Finance
Demystifying Ligand Pharmaceuticals: Insights From 10 Analyst Reviews - Benzinga
Ligand Pharmaceuticals' (LGND) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Ligand forecasts revenue growth and higher earnings for 2025 By Investing.com - Investing.com Canada
Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance - BioSpace
5,961 Shares in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Purchased by Verition Fund Management LLC - MarketBeat
Ligand forecasts revenue growth and higher earnings for 2025 - Investing.com
Ligand Pharmaceuticals Investor And Analyst Day At 10:30 AM ET - Nasdaq
Ashford Capital Management Inc. Sells 11,800 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Charles Schwab Investment Management Inc. Has $16.41 Million Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Erste Asset Management GmbH Purchases Shares of 4,300 Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Ligand Pharmaceuticals Insiders Sell US$6.3m Of Stock, Possibly Signalling Caution - Simply Wall St
RBC upgrades Ligand Pharma shares target ahead of guidance report By Investing.com - Investing.com Canada
RBC upgrades Ligand Pharma shares target ahead of guidance report - Investing.com
John L LaMattina At Ligand Pharmaceuticals Executes Options Exercise, Realizing $169K - Benzinga
Ligand Pharmaceuticals director John LaMattina sells $297,501 in stock By Investing.com - Investing.com Nigeria
Ligand Pharmaceuticals director John LaMattina sells $297,501 in stock - Investing.com
LGND (Ligand Pharmaceuticals) Shares Outstanding (EOP) : 18.8 Mil (As of Sep. 2024) - GuruFocus.com
34,069 Shares in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Bought by Edgestream Partners L.P. - MarketBeat
Isthmus Partners LLC Sells 9,622 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Fisher Asset Management LLC Purchases 6,555 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Loomis Sayles & Co. L P Buys 114,436 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Bought by Victory Capital Management Inc. - MarketBeat
Ligand Pharmaceuticals (FRA:LGDN) Inventories, Finished Goo - GuruFocus.com
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Analysts Set Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Target Price at $144.83 - MarketBeat
Ligand Pharmaceuticals' SWOT analysis: stock's growth potential in focus - Investing.com India
Royce & Associates LP Has $610,000 Stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Ligand Pharmaceuticals (STU:LGDN) Future 3-5Y EPS without N - GuruFocus.com
Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings - Yahoo Finance
Janus Henderson Group PLC Expands Stake in Ligand Pharmaceuticals Inc - GuruFocus.com
Ligand Pharmaceuticals to Present at Stifel 2024 Healthcare Conference | LGND Stock News - StockTitan
Royal Bank of Canada Forecasts Strong Price Appreciation for Ligand Pharmaceuticals (NASDAQ:LGND) Stock - MarketBeat
Ligand Pharmaceuticals (NASDAQ:LGND) Given New $150.00 Price Target at Barclays - Defense World
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):